Cargando…
Ciclosporin/everolimus/rituximab: COVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661306/ http://dx.doi.org/10.1007/s40278-021-06906-z |
Ejemplares similares
-
Ciclosporin/everolimus/prednisone: COVID-19 pneumonia: case report
Publicado: (2021) -
Ciclosporin/rituximab: Lack of efficacy and COVID-19: case report
Publicado: (2020) -
Ciclosporin/methylprednisolone: COVID-19 infection: case report
Publicado: (2022) -
Ciclosporin/methylprednisolone: COVID-19 infection: case report
Publicado: (2022) -
Epstein-Barr Virus Coinfection in COVID-19
por: Nadeem, Asim, et al.
Publicado: (2021)